# Insulin receptor trafficking and interactions in muscle cells

**Authors:** Haoning Howard Cen, Aurora J Mattison, Alireza Omidi, Jason Rogalski, Libin Abraham, Guang Gao, Michael R Gold, Leonard J Foster, Jörg Gsponer, James D Johnson

PMC · DOI: 10.1210/jendso/bvag020 · Journal of the Endocrine Society · 2026-01-28

## TL;DR

This study explores how insulin receptors move and interact in muscle cells, revealing new insights into their internalization and signaling pathways.

## Contribution

The study identifies novel INSR-binding proteins and demonstrates dual pathways for INSR internalization in muscle cells.

## Key findings

- INSR undergoes basal internalization in muscle cells independent of insulin.
- INSR interacts with both caveolin and clathrin pathways for internalization.
- High insulin levels alter INSR colocalization with caveolin and clathrin.

## Abstract

Insulin action is critical for energy homeostasis and its dysfunction in muscle cells is associated with type 2 diabetes. Insulin receptor (INSR) internalization and cell-surface dynamics at rest and during insulin exposure are incompletely understood in muscle cells.

We aimed to characterized the INSR dynamics and interactions in muscle.

We applied inter-domain tagged INSR, microscopy, immunoprecipitation, mass spectrometry, and AlphaFold multimer to comprehensively profile INSR internalization and interactions with or without insulin stimulation.

Using surface labeling and live-cell imaging, we observed robust basal internalization of INSR in C2C12 myoblasts, without an effect of added insulin. Mass spectrometry using INSR knockout cells as controls identified high-confidence binding partners, including proteins associated with internalization. We confirmed known interactors, including insulin-like growth factor 1 receptor, and also identified underappreciated INSR-binding factors, such as annexin A2. AlphaFold multimer analysis predicted potential INSR-binding sites of these proteins. Protein–protein interaction network mapping suggested links between INSR and caveolin-mediated endocytosis. INSR interacted with both caveolin and clathrin heavy chain (CLTC) in mouse skeletal muscle and C2C12 myoblasts. Whole-cell 2-dimensional super-resolution imaging revealed that high levels of insulin (20 nM) increased INSR colocalization with caveolin-1 (CAV1) but decreased its colocalization with CLTC. Single-particle tracking confirmed the colocalization of cell-surface INSR with both overexpressed CAV1-mRFP (monomeric red fluorescent protein) and CLTC-mRFP. INSR tracks that colocalized with CAV1 exhibited longer radii and lifetimes, regardless of insulin exposure, compared with noncolocalized tracks, whereas insulin further increased the lifetime of INSR/CLTC-colocalized tracks.

Overall, these data suggest that muscle cells utilize both CAV1- and CLTC-dependent pathways for INSR mobilization and internalization.

## Linked entities

- **Genes:** INSR (insulin receptor) [NCBI Gene 3643], CAV1 (caveolin 1) [NCBI Gene 857], CLTC (clathrin heavy chain) [NCBI Gene 1213]
- **Proteins:** CAV1 (caveolin 1), ANNAT2 (annexin 2)
- **Diseases:** type 2 diabetes (MONDO:0005148)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, Insr (insulin receptor) [NCBI Gene 16337] {aka 4932439J01Rik, CD220, D630014A15Rik, IR, IR-A, IR-B}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, Rpsa (ribosomal protein SA) [NCBI Gene 16785] {aka 67kDa, 67lr, Lamr, Lamr1, Lamrl1, MLR}, Hspb1 (heat shock protein family B (small) member 1) [NCBI Gene 15507] {aka 27kDa, Hsp25}, Igh-V7183 (immunoglobulin heavy chain (V7183 family)) [NCBI Gene 16059] {aka B9-scFv, IgG, IgH, IgVH1(VSG), VH7183, VI24H}, BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B) [NCBI Gene 701] {aka BUB1beta, BUBR1, Bub1A, MAD3L, MVA1, SSK1}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Foxo1 (forkhead box O1) [NCBI Gene 56458] {aka Afxh, FKHR, Fkhr1, Foxo1a}, CDC20 (cell division cycle 20) [NCBI Gene 991] {aka CDC20A, OOMD14, OZEMA14, bA276H19.3, p55CDC}, Igf1r (insulin-like growth factor I receptor) [NCBI Gene 16001] {aka A330103N21Rik, CD221, D930020L01, IGF-1R, hyft}, Appl2 (adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2) [NCBI Gene 216190] {aka DIP13 beta, Dip3 beta, Dip3b}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, H15 (histocompatibility 15) [NCBI Gene 109804] {aka H-15}, Myc (Myc proto-oncogene, bHLH transcription factor) [NCBI Gene 17869] {aka Myc2, Niard, Nird, bHLHe39}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Cav3 (caveolin 3) [NCBI Gene 12391] {aka Cav-3, M-cav}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Ap2m1 (adaptor-related protein complex 2, mu 1 subunit) [NCBI Gene 11773], Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Mapkapk5 (MAP kinase-activated protein kinase 5) [NCBI Gene 17165] {aka MK5, PRAK}, MAD2L1 (mitotic arrest deficient 2 like 1) [NCBI Gene 4085] {aka HSMAD2, MAD2}, CAV1 (caveolin 1) [NCBI Gene 857] {aka BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Hsbp1 (heat shock factor binding protein 1) [NCBI Gene 68196] {aka 0610007A03Rik, Hsp25}, Cav1 (caveolin 1, caveolae protein) [NCBI Gene 12389] {aka Cav, Cav-1}, MBOAT4 (membrane bound ghrelin O-acyltransferase MBOAT4) [NCBI Gene 619373] {aka FKSG89, GOAT, OACT4}, FLNA (filamin A) [NCBI Gene 2316] {aka ABP-280, ABPX, CSBS, CVD1, FGS2, FLN}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 17709], INSR (insulin receptor) [NCBI Gene 3643] {aka CD220, HHF5}, NR0B2 (nuclear receptor subfamily 0 group B member 2) [NCBI Gene 8431] {aka SHP, SHP1}, Irs1 (insulin receptor substrate 1) [NCBI Gene 16367] {aka G972R, IRS-1}, ANXA2 (annexin A2) [NCBI Gene 302] {aka ANX2, ANX2L4, CAL1H, HEL-S-270, LIP2, LPC2}, Egfr (epidermal growth factor receptor) [NCBI Gene 13649] {aka 9030024J15Rik, Erbb, Errb1, Errp, Wa5, wa-2}, H1f5 (H1.5 linker histone, cluster member) [NCBI Gene 56702] {aka H1-5, H1.5, H1B, H1s-3, Hist1h1b}, Anxa2 (annexin A2) [NCBI Gene 12306] {aka Cal1h, PAP-IV, p36}, Cltc (clathrin heavy chain) [NCBI Gene 67300] {aka 3110065L21Rik, CHC}, LMBRD1 (LMBR1 domain containing 1) [NCBI Gene 55788] {aka C6orf209, LMBD1, MAHCF, NESI}, CLTC (clathrin heavy chain) [NCBI Gene 1213] {aka CHC, CHC17, CLH-17, CLTCL2, Hc, MRD56}
- **Diseases:** hyperinsulinemic (MESH:D044903), hyperinsulinemia (MESH:D006946), tumor necrosis factor alpha (MESH:D005935), insulin resistance (MESH:D007333), Ewing sarcoma (MESH:D012512), type 2 diabetes (MESH:D003924), Disease (MESH:D004194), diabetes (MESH:D003920), obese (MESH:D009765), pTM (MESH:D004195), pLDDT (MESH:D013736)
- **Chemicals:** P36961 (-), penicillin (MESH:D010406), sodium (MESH:D012964), HEPES (MESH:D006531), ganglioside (MESH:D005732), beta-glycerol phosphate (MESH:C031463), phosphotyrosine (MESH:D019000), oil (MESH:D009821), Alexa Fluor 488 (MESH:C000711379), EGTA (MESH:D004533), glutathione (MESH:D005978), paraformaldehyde (MESH:C003043), lipid (MESH:D008055), PVDF (MESH:C024865), glucose (MESH:D005947), NaCl (MESH:D012965), sulfate (MESH:D013431), formic acid (MESH:C030544), ethylenediamine tetra-acetate (MESH:D004492), streptomycin (MESH:D013307), polyacrylamide (MESH:C016679), acetonitrile (MESH:C032159), Triton X-100 (MESH:D017830), water (MESH:D014867), NaF (MESH:D012969), peptides (MESH:D010455), sodium dodecyl sulfate (MESH:D012967), ACN (MESH:C084683), biotin (MESH:D001710), DTT (MESH:D004229), NaOH (MESH:D012972), C peptide (MESH:D002096)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** P35G
- **Cell lines:** Rat-1 — Rattus norvegicus (Rat), Spontaneously immortalized cell line (CVCL_0512), 8235S — Homo sapiens (Human), Acute myeloid leukemia, Cancer cell line (CVCL_T303), NIH3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188), AB_11129437 — Homo sapiens (Human), Bare lymphocyte syndrome type 2, Transformed cell line (CVCL_B7K5), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), 3T3L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), INSR- — Homo sapiens (Human), Embryonic stem cell (CVCL_XA15)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12963976/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12963976/full.md

## References

90 references — full list in the complete paper: https://tomesphere.com/paper/PMC12963976/full.md

---
Source: https://tomesphere.com/paper/PMC12963976